Skip to main content
Erschienen in: Cancer Chemotherapy and Pharmacology 3/2016

28.07.2016 | Original Article

Protein expression of ATP-binding cassette transporters ABCC10 and ABCC11 associates with survival of colorectal cancer patients

verfasst von: V. Krizkova, M. Dubova, S. Susova, O. Vycital, J. Bruha, M. Skala, V. Liska, O. Daum, P. Soucek

Erschienen in: Cancer Chemotherapy and Pharmacology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study investigated the prognostic importance of protein expression of ATP-binding cassette (ABC) transporters ABCC10 and ABCC11 in colorectal cancer.

Methods

Protein content of ABCC10 and ABCC11 was assessed in tumor tissue blocks of 140 colorectal cancer patients and associated with survival of patients with regard to 5-fluorouracil-based therapy.

Results

Low ABCC10 protein content in tumors increased hazard ratio of patient's death more than three times in comparison with high ABCC10-expressing tumors (P = 0.004). In contrast, the low ABCC11 content increased the hazard ratio of cancer recurrence in patients almost four times (P = 0.016). Analysis of patients treated with regimens based on 5-fluorouracil revealed that patients with low ABCC11 content in their tumors had shorter disease-free interval than those with higher content (P = 0.024).

Conclusions

The present study shows for the first time that the protein expression of ABCC10 significantly associates with overall survival and the expression of ABCC11 with disease-free interval of colorectal cancer patients and provides strong impulse for further validation of their prognostic value in colorectal cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMed
2.
Zurück zum Zitat Kathawala RJ, Gupta P, Ashby CR Jr et al (2015) The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updat 18:1–17CrossRefPubMed Kathawala RJ, Gupta P, Ashby CR Jr et al (2015) The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Updat 18:1–17CrossRefPubMed
3.
Zurück zum Zitat Fletcher JI, Haber M, Henderson MJ et al (2010) ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer 10:147–156CrossRefPubMed Fletcher JI, Haber M, Henderson MJ et al (2010) ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer 10:147–156CrossRefPubMed
4.
Zurück zum Zitat Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162CrossRefPubMed Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162CrossRefPubMed
5.
Zurück zum Zitat Cole SPC, Bhardwaj G, Gerlach JH et al (1992) Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science 258:1650–1654CrossRefPubMed Cole SPC, Bhardwaj G, Gerlach JH et al (1992) Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science 258:1650–1654CrossRefPubMed
6.
Zurück zum Zitat Doyle LA, Yang W, Abruzzo LV et al (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95:15665–15670CrossRefPubMed Doyle LA, Yang W, Abruzzo LV et al (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA 95:15665–15670CrossRefPubMed
7.
Zurück zum Zitat Hlavata I, Mohelnikova-Duchonova B, Vaclavikova R et al (2012) The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis 27:187–196CrossRefPubMed Hlavata I, Mohelnikova-Duchonova B, Vaclavikova R et al (2012) The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis 27:187–196CrossRefPubMed
8.
Zurück zum Zitat Mohelnikova-Duchonova B, Brynychova V, Oliverius M et al (2013) Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and non-neoplastic tissues. Pancreas 42:707–716CrossRefPubMed Mohelnikova-Duchonova B, Brynychova V, Oliverius M et al (2013) Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and non-neoplastic tissues. Pancreas 42:707–716CrossRefPubMed
9.
Zurück zum Zitat Hlavac V, Brynychova V, Vaclavikova R et al (2013) The expression profile of ABC transporter genes in breast carcinoma. Pharmacogenomics 14:515–529CrossRef Hlavac V, Brynychova V, Vaclavikova R et al (2013) The expression profile of ABC transporter genes in breast carcinoma. Pharmacogenomics 14:515–529CrossRef
10.
Zurück zum Zitat Tonar Z, Witter K, Krizkova V et al (2010) Stereological tools for quantitative microscopy of the aortic wall with focus on the abdominal aortic aneurysm. In: Méndez-Vilas A, Díaz J (eds) Microscopy: science, technology, applications and education. applications in biology and medicine. Formatex Research Centre, Badajoz, 926–935 Tonar Z, Witter K, Krizkova V et al (2010) Stereological tools for quantitative microscopy of the aortic wall with focus on the abdominal aortic aneurysm. In: Méndez-Vilas A, Díaz J (eds) Microscopy: science, technology, applications and education. applications in biology and medicine. Formatex Research Centre, Badajoz, 926–935
11.
Zurück zum Zitat Budczies J, Klauschen F, Sinn BV et al (2012) Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PLoS ONE 7:e51862CrossRefPubMedPubMedCentral Budczies J, Klauschen F, Sinn BV et al (2012) Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PLoS ONE 7:e51862CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Hopper E, Belinsky MG, Zeng H et al (2001) Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. Cancer Lett 162:181–191CrossRefPubMed Hopper E, Belinsky MG, Zeng H et al (2001) Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. Cancer Lett 162:181–191CrossRefPubMed
13.
Zurück zum Zitat Karatas OF, Guzel E, Duz MB et al (2016) The role of ATP-binding cassette transporter genes in the progression of prostate cancer. Prostate 76:434–444CrossRefPubMed Karatas OF, Guzel E, Duz MB et al (2016) The role of ATP-binding cassette transporter genes in the progression of prostate cancer. Prostate 76:434–444CrossRefPubMed
14.
Zurück zum Zitat Chen Z-S, Hopper-Borge E, Belinsky MG et al (2003) Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Mol Pharmacol 63:351–358CrossRefPubMed Chen Z-S, Hopper-Borge E, Belinsky MG et al (2003) Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10). Mol Pharmacol 63:351–358CrossRefPubMed
15.
Zurück zum Zitat Hopper-Borge E, Xu X, Shen T et al (2009) Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B. Cancer Res 69:178–184CrossRefPubMedPubMedCentral Hopper-Borge E, Xu X, Shen T et al (2009) Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B. Cancer Res 69:178–184CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Bera TK, Lee S, Salvatore G et al (2001) MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol Med 7:509–516PubMedPubMedCentral Bera TK, Lee S, Salvatore G et al (2001) MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol Med 7:509–516PubMedPubMedCentral
17.
Zurück zum Zitat Turriziani O, Schuetz JD, Focher F et al (2002) Impaired 2′,3′-dideoxy-3′-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11. Biochem J 368:325–332CrossRefPubMedPubMedCentral Turriziani O, Schuetz JD, Focher F et al (2002) Impaired 2′,3′-dideoxy-3′-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11. Biochem J 368:325–332CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Oguri T, Bessho Y, Achiwa H et al (2007) MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol Cancer Ther 6:122–127CrossRefPubMed Oguri T, Bessho Y, Achiwa H et al (2007) MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol Cancer Ther 6:122–127CrossRefPubMed
19.
Zurück zum Zitat Yamada A, Ishikawa T, Ota I et al (2013) High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival. Breast Cancer Res Treat 137:773–782CrossRefPubMedPubMedCentral Yamada A, Ishikawa T, Ota I et al (2013) High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival. Breast Cancer Res Treat 137:773–782CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Magdy T, Arlanov R, Winter S et al (2013) ABCC11/MRP8 polymorphisms affect 5-fluorouracil-induced severe toxicity and hepatic expression. Pharmacogenomics 14:1433–1448CrossRefPubMed Magdy T, Arlanov R, Winter S et al (2013) ABCC11/MRP8 polymorphisms affect 5-fluorouracil-induced severe toxicity and hepatic expression. Pharmacogenomics 14:1433–1448CrossRefPubMed
21.
Zurück zum Zitat Arlanov R, Lang T, Jedlitschky G et al (2016) Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546 M as functionally damaging variant. Pharmacogenomics J 16:193–201CrossRefPubMed Arlanov R, Lang T, Jedlitschky G et al (2016) Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546 M as functionally damaging variant. Pharmacogenomics J 16:193–201CrossRefPubMed
Metadaten
Titel
Protein expression of ATP-binding cassette transporters ABCC10 and ABCC11 associates with survival of colorectal cancer patients
verfasst von
V. Krizkova
M. Dubova
S. Susova
O. Vycital
J. Bruha
M. Skala
V. Liska
O. Daum
P. Soucek
Publikationsdatum
28.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Chemotherapy and Pharmacology / Ausgabe 3/2016
Print ISSN: 0344-5704
Elektronische ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-016-3114-7

Weitere Artikel der Ausgabe 3/2016

Cancer Chemotherapy and Pharmacology 3/2016 Zur Ausgabe

Editorial

Editorial

Editorial

Editorial

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.